14.9. Analysis.

Comparison 14 BPO/clindamycin versus placebo or no treatment, Outcome 9 Percentage of participants with any adverse events (long‐term data).

Comparison 14 BPO/clindamycin versus placebo or no treatment, Outcome 9 Percentage of participants with any adverse events (long‐term data).